Reader-supported. We may earn a commission when you use our partner links. How we’re funded

Our take

Brello is a practical comparison for a bundled injection service. I would judge affordability by its $349 charge and eleven-week renewal calendar, not the smaller monthly headline.

$349 upfront and every 11 weeks$349 today, then every 11 weeks; advertised as $116/mo
InjectionFormat offered
Prescription requiredSubject to clinical evaluation

What stands out

  • Full upfront and renewal charges published
  • Medication, injection supplies and health review listed
  • Full refund advertised if prescription is declined

What to weigh

  • Three-month minimum commitment
  • Renewal occurs every eleven weeks
  • Possible $50 cancellation fee after provider review

The payment calendar matters more than the headline

Brello makes sense to investigate when you want medication, supplies and support in one program. Its main comparison problem is timing. The product is presented as a three-month plan, but the next $349 charge arrives after eleven weeks. That is the figure and date I would put in a household budget.

The smaller monthly equivalent can help compare headline prices, yet it does not describe what leaves your account each month. Before enrolling, request the next renewal date and shipment schedule together. If those dates differ, understand how the service avoids both a treatment gap and more medication arriving than you need.

A longer purchase may be reasonable after a clinician has established a plan. It is less attractive if you are still deciding whether injections fit your routine or whether the underlying concern needs a different evaluation.

The useful parts of the package

The injection kit, health review and app support are the practical elements of this offer. Brello also promotes fitness and nutrition classes and a private community. Those extras may be welcome, but I would assign them value only if you expect to use them. A class library should not distract from the medication quantity or clinical access.

Request a simple description of the proposed prescription: ingredients, concentration, total quantity, pharmacy and intended supply period. A package photograph does not answer those questions. It is also worth confirming whether every supply needed for your prescribed product arrives together.

For a first injection order, instructions and access to someone who can explain them matter more than a large box. Our preparation guide explains why directions must come from the dispensing pharmacy for the actual formulation.

Payment comes before the treatment decision

The stated process places payment ahead of the medical intake, with a refund if treatment is not approved. I would read that as an administrative sequence, not a promise of a prescription. Complete the health questions carefully and raise uncertainties before consenting to the final treatment plan.

The product FAQ separately says Brello may refund payment minus a $50 professional-services fee after the review and prescription, if contacted within 24 hours of the completed review. This is a possible refund, not a guarantee. The same FAQ contains a semaglutide reference, so confirm which terms govern this sermorelin order.

Ask what happens if the recommendation changes or if the clinician advises stopping before a subsequent shipment. Those answers are especially useful when a plan charges several months at once.

Support should have a clear clinical route

An app can make communication convenient, but the important question is who receives each message. I would want a clear route for a prescription concern, a delivery problem and a billing change. A community group can be helpful socially; it should not become the place where treatment decisions are made.

Establish when the clinician expects to reassess you and what information will make that appointment useful. The goal is to evaluate the original concern, not simply decide whether another box should ship. Ask whether recommended testing or extra visits would create additional charges.

Our results timeline review provides context for that conversation. An advertised sequence of weeks cannot tell an individual whether treatment is helping, and a purchase commitment is not a clinical reason to continue.

My assessment of the offer

Brello belongs on a shortlist for readers comfortable with an injection package and a larger recurring payment. Its clearly displayed charge is helpful. The eleven-week renewal is the feature I would investigate most carefully, because it changes how the apparently monthly offer behaves in practice.

I would compare it with another provider using the same supply period, the same included services and the amount payable before treatment begins. If a competing option costs more per month but allows a smaller initial commitment, that flexibility may be worth paying for.

This review is based on public information checked in October 2026, not a treatment experience or independent testing. Compounded sermorelin is not FDA-approved. The next useful step is a clinical discussion and an itemized plan, followed by a comparison with other injection providers.

Common questions

Is Brello sermorelin $116 billed monthly?

No. The current product page shows $349 due initially and again every eleven weeks for its three-month plan. The monthly headline is a comparison figure.

What happens if I am not approved?

Brello says it provides a full refund if the healthcare provider does not approve treatment after the post-checkout intake.

Is this an oral product?

The verified offer includes syringes, needles and injection instructions. We verified an injection plan, not an oral or nasal sermorelin option.

Explore Brello Health

See the current offer and decide whether you want to start a consultation.

Visit Brello Health

Reader-supported. We may earn a commission when you use our partner links. How we’re funded

Sources & further reading

Sources reviewed October 2026. Provider prices and terms may change.

  1. Brello Health website
  2. FDA: Understanding the risks of compounded drugs
  3. Endocrine Society: Hormones and Aging scientific statement